310 related articles for article (PubMed ID: 25710838)
1. Reprogramming patient-derived cells to study the epilepsies.
Parent JM; Anderson SA
Nat Neurosci; 2015 Mar; 18(3):360-6. PubMed ID: 25710838
[TBL] [Abstract][Full Text] [Related]
2. Using Patient-Derived Induced Pluripotent Stem Cells to Model and Treat Epilepsies.
Du X; Parent JM
Curr Neurol Neurosci Rep; 2015 Oct; 15(10):71. PubMed ID: 26319172
[TBL] [Abstract][Full Text] [Related]
3. Modeling genetic epilepsies in a dish.
Niu W; Parent JM
Dev Dyn; 2020 Jan; 249(1):56-75. PubMed ID: 31241228
[TBL] [Abstract][Full Text] [Related]
4. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
[TBL] [Abstract][Full Text] [Related]
5. [Induced pluripotent stem cells: a new paradigm to study human tissues].
Sansac C; Assou S; Bouckenheimer J; Lemaître JM; De Vos J
Biol Aujourdhui; 2016; 210(1):1-8. PubMed ID: 27286575
[TBL] [Abstract][Full Text] [Related]
6. A developmental framework for induced pluripotency.
Takahashi K; Yamanaka S
Development; 2015 Oct; 142(19):3274-85. PubMed ID: 26443632
[TBL] [Abstract][Full Text] [Related]
7. Stem cell reprogramming: basic implications and future perspective for movement disorders.
Brändl B; Schneider SA; Loring JF; Hardy J; Gribbon P; Müller FJ
Mov Disord; 2015 Mar; 30(3):301-12. PubMed ID: 25546831
[TBL] [Abstract][Full Text] [Related]
8. Reprogramming of human cancer cells to pluripotency for models of cancer progression.
Kim J; Zaret KS
EMBO J; 2015 Mar; 34(6):739-47. PubMed ID: 25712212
[TBL] [Abstract][Full Text] [Related]
9. Advances in reprogramming-based study of neurologic disorders.
Nityanandam A; Baldwin KK
Stem Cells Dev; 2015 Jun; 24(11):1265-83. PubMed ID: 25749371
[TBL] [Abstract][Full Text] [Related]
10. Stem cells: A path towards improved epilepsy therapies.
Lybrand ZR; Goswami S; Hsieh J
Neuropharmacology; 2020 May; 168():107781. PubMed ID: 31539537
[TBL] [Abstract][Full Text] [Related]
11. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
[TBL] [Abstract][Full Text] [Related]
12. Modeling Hematological Diseases and Cancer With Patient-Specific Induced Pluripotent Stem Cells.
Kim H; Schaniel C
Front Immunol; 2018; 9():2243. PubMed ID: 30323816
[TBL] [Abstract][Full Text] [Related]
13. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
[TBL] [Abstract][Full Text] [Related]
14. A new era of disease modeling and drug discovery using induced pluripotent stem cells.
Suh W
Arch Pharm Res; 2017 Jan; 40(1):1-12. PubMed ID: 27921262
[TBL] [Abstract][Full Text] [Related]
15. Solving the puzzle of Parkinson's disease using induced pluripotent stem cells.
Zhao P; Luo Z; Tian W; Yang J; Ibáñez DP; Huang Z; Tortorella MD; Esteban MA; Fan W
Exp Biol Med (Maywood); 2014 Nov; 239(11):1421-32. PubMed ID: 24939824
[TBL] [Abstract][Full Text] [Related]
16. Can controlled cellular reprogramming be achieved using microRNAs?
Sun X; Fu X; Han W; Zhao Y; Liu H
Ageing Res Rev; 2010 Oct; 9(4):475-83. PubMed ID: 20601195
[TBL] [Abstract][Full Text] [Related]
17. Reprogramming of human somatic cells by bacteria.
Ito N; Ohta K
Dev Growth Differ; 2015 May; 57(4):305-12. PubMed ID: 25866152
[TBL] [Abstract][Full Text] [Related]
18. Reprogramming in suspension.
Chen J; Pei D
Nat Methods; 2012 Apr; 9(5):449-51. PubMed ID: 22543375
[No Abstract] [Full Text] [Related]
19. Efficient episomal reprogramming of blood mononuclear cells and differentiation to hepatocytes with functional drug metabolism.
Liu J; Brzeszczynska J; Samuel K; Black J; Palakkan A; Anderson RA; Gallagher R; Ross JA
Exp Cell Res; 2015 Nov; 338(2):203-13. PubMed ID: 26256888
[TBL] [Abstract][Full Text] [Related]
20. Striatal Transplantation of Human Dopaminergic Neurons Differentiated From Induced Pluripotent Stem Cells Derived From Umbilical Cord Blood Using Lentiviral Reprogramming.
Effenberg A; Stanslowsky N; Klein A; Wesemann M; Haase A; Martin U; Dengler R; Grothe C; Ratzka A; Wegner F
Cell Transplant; 2015; 24(10):2099-112. PubMed ID: 25420114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
